Legal Representation
Attorney
Mark C. Reichel
USPTO Deadlines
Next Deadline
2067 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-03-11)
Due Date
March 11, 2031
Grace Period Ends
September 11, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
16 eventsDate | Code | Type | Description |
---|---|---|---|
Mar 11, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
Mar 11, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
Jan 21, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Jan 21, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION |
Jan 15, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Oct 24, 2024 | ALIE | A | ASSIGNED TO LIE |
Oct 24, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Oct 24, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Oct 24, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
Jul 18, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
May 20, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
May 20, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
May 20, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED |
May 20, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN |
Oct 11, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Sep 30, 2023 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical and medical preparations for patients suffering from dysphagia and conditions requiring medication in liquid form for the treatment of viral, bacterial, parasitic and fungal diseases and infections; oral liquid medicines for the treatment of viral, bacterial, parasitic and fungal diseases and infections; drugs for medical purposes in the nature of medicines for the treatment of viral, bacterial, parasitic and fungal diseases and infections; substances, drugs, medicines and medical preparations, namely, drug delivery agents consisting of compounds in the form of oral liquid medicines, oral suspensions, dispersible and soluble tablets, and powders to be consumed in liquid form, that facilitate the delivery of a wide range of pharmaceuticals; substances, drugs, medicines and medical preparations, namely, drug delivery agents consisting of compounds in the form of oral liquid medicines, oral suspensions, dispersible and soluble tablets, and powders to be consumed in liquid form, that facilitate the delivery of anti-infective agents, antineoplastic agents, cardiovascular agents, central nervous system agents, coagulation modifiers, gastrointestinal agents, genitourinary tract agents, psychotherapeutic agents and metabolic agents
Classification
International Classes
005
USPTO Documents
Loading USPTO documents...